Fundz

Galecto, Inc. Acquires Damora Therapeutics, Inc.

PUBLIC · DMRANov 10, 2025

Acquiring Company

Galecto

CopenhagenBiotechnologyHealthcareHealth CareMedicalTherapeutics

Description

On November 10, 2025, Galecto, Inc. completed the acquisition of Damora Therapeutics, Inc. The acquisition was executed through a series of mergers where Damora became a wholly owned subsidiary of Galecto. This strategic move aims to enhance Galecto's portfolio in the biotechnology sector.

Company Information

Company

Galecto

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Galecto is a clinical-stage biotechnology company developing novel small-molecule therapeutics that target the core biological drivers of fibrosis, inflammation, and cancer. Founded by leading scientists and biotech executives with more than a decade of research into galectin biology and LOXL2 modulation, the company has built deep expertise in pathways central to complex and often devastating diseases. Galecto is backed by prominent investors including Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure, and SEED Capital.

Fundz sees it the moment Galecto makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Lori
Senior decision-maker at this company
••••••••@••••••••

See Lori's verified email →

Sylwia
Likely contact at this company
••••••••@••••••••

See Sylwia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Galecto's next move

Learn about Strategic plan

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.